Dose-dependent increase of saquinavir bioavailability by the pharmaceutic aid cremophor EL.

@article{MartinFacklam2002DosedependentIO,
  title={Dose-dependent increase of saquinavir bioavailability by the pharmaceutic aid cremophor EL.},
  author={M. Martin-Facklam and J. Burhenne and R. Ding and R. Fricker and G. Mikus and I. Walter-Sack and W. Haefeli},
  journal={British journal of clinical pharmacology},
  year={2002},
  volume={53 6},
  pages={
          576-81
        }
}
  • M. Martin-Facklam, J. Burhenne, +4 authors W. Haefeli
  • Published 2002
  • Medicine
  • British journal of clinical pharmacology
  • AIMS Bioavailability of orally administered drugs depends on several factors including active excretion, e.g. by P-glycoprotein (PGP), and presystemic metabolism, e.g. by cytochrome P450 3A (CYP3A), in both gastrointestinal tract and liver. Many drugs including saquinavir are substrates of both PGP and CYP3A. It was the aim of this study to test whether the extremely low bioavailability of saquinavir can be increased dose-dependently in vivo by cremophor EL, an 'inactive' pharmaceutic aid known… CONTINUE READING
    68 Citations
    Reduction of Saquinavir Exposure by Coadministration of Loperamide
    • 7
    Oral contraception does not alter single dose saquinavir pharmacokinetics in women.
    • 27
    Docosahexaenoic acid (DHA) inhibits saquinavir metabolism in‐vitro and enhances its bioavailability in rats
    • 11
    Pharmacokinetic interaction of enrofloxacin/trimethoprim combination following single-dose intraperitoneal and oral administration in rats
    • 1
    A Modern View of Excipient Effects on Bioequivalence: Case Study of Sorbitol
    • 69

    References

    SHOWING 1-10 OF 17 REFERENCES
    Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics.
    • 415
    Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir.
    • 327
    • PDF
    The disposition of saquinavir in normal and P-glycoprotein deficient mice, rats, and in cultured cells.
    • 94
    • PDF
    Pharmacokinetic Interaction between Ritonavir and Indinavir in Healthy Volunteers
    • 143
    • PDF
    HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter.
    • 477